Inactive on SAM.gov — responses were due 22 Jun 2026 · No Set aside used · Food and Drug Administration (FDA), HHS · Silver Spring, MD · NAICS 333914 · Solicitation 75F40126Q00231
Following NAICS 333914? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 22 June 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
This one has closed. We'll email you when new NAICS 333914 (Measuring, Dispensing, and Other Pumping Equipment Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
Semiautomatic Aerosol Propellant Filler for pMDI Two-Stage Formulation Brand Name or Equal This is a Request for Quotation (RFQ) for commercial products prepared in accordance with FAR Part 12 and FAR Part 13 procedures utilizing the FAR Revolutionary FAR Overhaul clauses and provisions available at Acquisition.gov. The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Testing and Research (OTR), requires the purchase, delivery, installation, validation support, training, and warranty of a Semiautomatic Aerosol Propellant Filler for pMDI Two-Stage Formulation. The requirement supports FDA research in advanced pharmaceutical manufacturing and inhalation drug delivery systems. Please refer to the following attachments for all the pertinent details of this requirement Attachment I Statement of Work (SOW) Attachment II Pricing Schedule Attachment III Past Performance Reference Form Attachment IV SF-18 Request for Quotations Attachment V Brand Name or Equal Compliance Matrix Attachment VI Buy American Certificate Attachment VII Solicitation Document Submit all questions in writing via email to Michele.Jackson@fda.hhs.gov no later than: June 15, 2026, at 9:00 AM Eastern Time Questions received after this date may not receive a response. Submit quotations electronically to Michele.Jackson@fda.hhs.gov no later than June 22, 2026, at 11:00 AM Eastern Time Include in the Subject Line: [Company Name] 75F40126Q00231/CDER-2026-133243 Quote
Go deeper on this solicitation
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
